$NXL Balance Sheet | Understand Stock

$NXL

$1.60 -$0.03 (1.84%) Close

$NXL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022
ASSETS
Current Assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, including related party receivables of $7,974 and $37,812, respectively
Inventory
Prepaid expenses
Prepaid expenses and other current assets
Total Current Assets
ROU Asset
Equipment, net of accumulated depreciation of $6,790 and $0, respectively
Other assets
Other assets
Equipment, net of accumulated depreciation of $9,527 and $2,683, respectively
Intangible assets, net
Total Assets

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable
Accrued expenses
Lease liability, current portion
Loan payable - officer
Note payable
Deferred share obligation (Note 4)
Total Current Liabilities

Lease liability, net of current portion
Total Liabilities
Stockholders’ Equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 22,003,706 and 19,186,346 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Accumulated other comprehensive loss
Additional paid in capital
Accumulated deficit
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Comments